MENLO PARK, Calif. and MADISON, Wis., May 23, 2024 - Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, today announced that it.
MENLO PARK, Calif., Feb. 15, 2023 /PRNewswire/ Gamma Biosciences ("Gamma"), a global life sciences platform formed by KKR to address the advanced therapy market with best-in-class bioprocessing
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Capital Increase Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million (news
Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets KKR, a leading global investment firm, announced today